Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.137
-0.043 (-3.64%)
Nov 22, 2024, 4:00 PM EST - Market closed
Dermata Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 4.39 | 3.97 | 4.02 | 4.4 | 1.57 | 1.85 |
| Research & Development | 7.15 | 4.07 | 5.65 | 3.46 | 1.61 | 2.62 |
| Operating Expenses | 11.53 | 8.04 | 9.67 | 7.86 | 3.17 | 4.47 |
| Operating Income | -11.53 | -8.04 | -9.67 | -7.86 | -3.17 | -4.47 |
| Interest Expense | - | - | - | -0.05 | -0.2 | -0.25 |
| Interest & Investment Income | 0.26 | 0.25 | 0.06 | - | - | - |
| EBT Excluding Unusual Items | -11.27 | -7.79 | -9.61 | -7.9 | -3.37 | -4.72 |
| Other Unusual Items | - | - | - | - | 0.13 | - |
| Pretax Income | -11.27 | -7.79 | -9.61 | -7.9 | -3.24 | -4.72 |
| Net Income | -11.27 | -7.79 | -9.61 | -7.9 | -3.24 | -4.72 |
| Preferred Dividends & Other Adjustments | - | - | - | 2.56 | - | - |
| Net Income to Common | -11.27 | -7.79 | -9.61 | -10.46 | -3.24 | -4.72 |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | - | - |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | - | - |
| Shares Change (YoY) | 486.90% | 323.42% | 156.86% | - | - | - |
| EPS (Basic) | -15.02 | -39.98 | -208.73 | -583.77 | - | - |
| EPS (Diluted) | -15.02 | -39.98 | -208.73 | -583.77 | - | - |
| Free Cash Flow | -9.4 | -6.41 | -8.83 | -5.69 | -4.03 | -3.92 |
| Free Cash Flow Per Share | -12.52 | -32.87 | -191.86 | -317.61 | - | - |
| EBITDA | - | - | - | -7.86 | -3.17 | -4.47 |
| D&A For EBITDA | - | - | - | 0 | 0 | 0 |
| EBIT | -11.53 | -8.04 | -9.67 | -7.86 | -3.17 | -4.47 |
Source: S&P Capital IQ. Standard template.
Financial Sources.